Hasil Pencarian - Kimberly T. Webster
- Menampilkan 1 - 8 hasil dari 8
-
1
Written Verb Naming Improves After tDCS Over the Left IFG in Primary Progressive Aphasia oleh Amberlynn S. Fenner, Kimberly T. Webster, Kimberly T. Webster, Bronte N. Ficek, Constantine E. Frangakis, Constantine E. Frangakis, Constantine E. Frangakis, Kyrana Tsapkini, Kyrana Tsapkini
Diterbitkan 2019-06-01
Artikel -
2
-
3
Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin’s lymp... oleh Courtney N. Hurt, Karen Kaiser, Sara Shaunfield, Kimberly A. Webster, Karen Keating, Lara Boyken, Sara Duffey, Jessica Garcia, David Cella
Diterbitkan 2024-07-01
Artikel -
4
Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record-integrated patient-reported symptom monitoring in a... oleh David Cella, Justin D Smith, Frank J Penedo, Sofia F Garcia, Michael Kallen, Kimberly A Webster, Madison Lyleroehr, Sheetal Kircher, Michael Bass
Diterbitkan 2022-05-01
Artikel -
5
The effect of tDCS on functional connectivity in primary progressive aphasia oleh Bronte N. Ficek, Zeyi Wang, Yi Zhao, Kimberly T. Webster, John E. Desmond, Argye E. Hillis, Constantine Frangakis, Andreia Vasconcellos Faria, Brian Caffo, Kyrana Tsapkini
Diterbitkan 2018-01-01
Artikel -
6
“The effect of tDCS on functional connectivity in primary progressive aphasia” NeuroImage: Clinical, volume 19 (2018), pages 703–715 oleh Bronte N. Ficek, Zeyi Wang, Yi Zhao, Kimberly T. Webster, John E. Desmond, Argye E. Hillis, Constantine Frangakis, Andreia Vasconcellos Faria, Brian Caffo, Kyrana Tsapkini
Diterbitkan 2019-01-01
Artikel -
7
A mixed methods evaluation of patient perspectives on the implementation of an electronic health record-integrated patient-reported symptom and needs monitoring program in cancer c... oleh Madison J. Lyleroehr, Kimberly A. Webster, Laura M. Perry, Elijah A. Patten, Jackelyn Cantoral, Justin D. Smith, David Cella, Frank J. Penedo, Sofia F. Garcia
Diterbitkan 2024-07-01
Artikel -
8
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. oleh John Devin Peipert, Austin G Kulasekararaj, Anna Gaya, Saskia M C Langemeijer, Susan Yount, F Ataulfo Gonzalez-Fernandez, Emilio Ojeda Gutierrez, Christa Martens, Amy Sparling, Kimberly A Webster, David Cella, Ioannis Tomazos, Masayo Ogawa, Caroline I Piatek, Richard Wells, Flore Sicre de Fontbrune, Alexander Röth, Lindsay Mitchell, Anita Hill, Karen Kaiser
Diterbitkan 2020-01-01
Artikel